{"id":"W2067495120","doi":"10.1007/s00280-011-1606-z","title":"A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"FOLFOX; Oxaliplatin; Bevacizumab; Capecitabine; Medicine; Pharmacokinetics; Dosing; Colorectal cancer; Internal medicine; Oncology; Chemotherapy; Pharmacology; Gastroenterology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002692366,0.0003393633,0.001060996,0.00009947527,0.00009547981,0.0000162439,0.000215752,0.00002707238,0.0008348282],"category_scores_gemma":[0.000007616525,0.0001652979,0.00003574166,0.0003473207,0.0003127902,0.00008885442,0.00009833516,0.0001917936,8.186775e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000160629,"about_ca_system_score_gemma":0.0002301976,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001781925,"about_ca_topic_score_gemma":0.002935429,"domain_scores_codex":[0.9983496,0.0002500813,0.0003885885,0.0004278497,0.0002301447,0.0003537388],"domain_scores_gemma":[0.9990618,0.0002027815,0.0002310908,0.0001368815,0.0002400282,0.0001274121],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7202562,0.006959935,0.2173601,0.0001207448,0.004748732,0.00005049658,0.02918829,0.00001892043,0.0007448877,0.000001902844,0.0003239856,0.02022583],"study_design_scores_gemma":[0.827695,0.01215871,0.1385649,0.0001832027,0.002355944,0.000005234772,0.001837999,0.0001933224,0.01565024,0.000009447549,0.0009604353,0.0003855156],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904628,0.001049259,0.00002514362,0.0005792287,0.0002025342,0.00729871,0.00008684588,0.00001448756,0.0002810116],"genre_scores_gemma":[0.9930152,0.001486984,0.0003909581,0.001830116,0.00003558898,0.002834733,0.000003682158,0.00004873228,0.0003539851],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1074388,"threshold_uncertainty_score":0.9140783,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06911846102860347,"score_gpt":0.3775572727830627,"score_spread":0.3084388117544593,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}